ReviewAnnals of laboratory medicine2019
Review in Annals of laboratory medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 23 citations in OpenAlex.
- Establishment of a case registry that collaborates with a reference laboratory for blood group immunogenetics in Korea.Blood transfusion = Trasfusione del sangue · 2024Article
- Mechanisms of Formation of Antibodies against Blood Group Antigens That Do Not Exist in the Body.International journal of molecular sciences · 2023Article
- Allelic Enhancement ofAnnals of laboratory medicine · 2023Article
- Investigation of Discrepant ABO Blood Grouping Results from an Autoanalyzer.Annals of laboratory medicine · 2022Article
- AccurateClinical case reports · 2021Article
- ABO-Incompatible Transfusion Events Reported in Written Judgments and in the Korean Hemovigilance System.Annals of laboratory medicine · 2021Article
- ABO Genetic Variation in Neanderthals and Denisovans.Molecular biology and evolution · 2021Article
- A Clinical Case of Weak A Antigen on the Erythrocytes in a Person with Coexistent Anti-A Antibodies.Archives of Razi Institute · 2020Article
- A or AB? Resolving the dilemma of weaker subgroup through serological evaluation: Reporting two cases from Uttarakhand.Asian journal of transfusion scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.